Abstract:Soft tissue fibrosis in important organs such as the heart, liver, lung, and kidney is a serious pathological process that is characterized by excessive connective tissue deposition. It is the result of chronic but progressive accumulation of fibroblasts and their production of extracellular matrix components such as collagens. Research on pathological scars, namely, hypertrophic scars and keloids, may provide important clues about the mechanisms that drive soft tissue fibrosis, in particular the vascular involvement. This is because these dermal fibrotic lesions bear all of the fibrotic characteristics seen in soft tissue fibrosis. Moreover, their location on the skin surface means they are readily observable and directly treatable and therefore more accessible to research. We will focus here on the roles that blood vessel-associated cells play in cutaneous scar pathology and assess from the literature whether these cells also contribute to other soft tissue fibroses. These cells include endothelial cells, which not only exhibit aberrant functions but also differentiate into mesenchymal cells in pathological scars. They also include pericytes, hepatic stellate cells, fibrocytes, and myofibroblasts. This article will review with broad strokes the roles that these cells play in the pathophysiology of different soft tissue fibroses. We hope that this brief but wide-ranging overview of the vascular involvement in fibrosis pathophysiology will aid research into the mechanisms underlying fibrosis and that this will eventually lead to the development of interventions that can prevent, reduce, or even reverse fibrosis formation and/or progression.

Fibroblasts: Heterogeneous Cells With Potential in Regenerative Therapy for Scarless Wound Healing

Improved Dermal Regeneration Using a Combination of Dermal Substitutes and Dermal Fibroblast Optimization: A Hypothesis.

Novel Prospects for Scarless Wound Healing: the Roles of Myofibroblasts and Adipocytes.

Co-transfection of Hepatocyte Growth Factor and Truncated TGF-β Type II Receptor Inhibit Scar Formation

Theoretical and Practical Aspects of Using Fetal Fibroblasts for Skin Regeneration

Fibrocytes: a Potential Therapeutic Cell Population in Chronic Wounds.

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Diversity of fibroblasts--a review on implications for skin tissue engineering

Emerging biomedical technologies for scarless wound healing

Scarring Skin: Mechanisms and Therapies

Application of ADSCs and their Exosomes in Scar Prevention

Mechanisms and Therapies

The Anti-Scar Effects of Basic Fibroblast Growth Factor on the Wound Repair in Vitro and in Vivo

Nature-Inspired Scarless Healing: Guiding Biomaterials Design for Advanced Therapies

New insights into balancing wound healing and scarless skin repair

Substrate Stiffness and Topography Affect the Morphology of Human Fibroblasts in Mechanical Microenvironment

TGF-β: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy

The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring

Contribution of Epidermal Stem Cells to Hypertrophic Scars Pathogenesis

Identifying Characteristics of Dermal Fibroblasts in Skin Homeostasis and Disease

Down-Regulating Scar Formation by Microneedles Directly via a Mechanical Communication Pathway